277 related articles for article (PubMed ID: 17570417)
1. Validation of the overactive bladder symptom score.
Blaivas JG; Panagopoulos G; Weiss JP; Somaroo C
J Urol; 2007 Aug; 178(2):543-7; discussion 547. PubMed ID: 17570417
[TBL] [Abstract][Full Text] [Related]
2. Reliability and validity of the Overactive Bladder Symptom Score in Spanish (OABSS-S).
Weinberg AC; Brandeis GH; Bruyere J; Tsui JF; Weiss JP; Rutman MP; Blaivas JG
Neurourol Urodyn; 2012 Jun; 31(5):664-8. PubMed ID: 22488591
[TBL] [Abstract][Full Text] [Related]
3. Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ).
Matza LS; Thompson CL; Krasnow J; Brewster-Jordan J; Zyczynski T; Coyne KS
Neurourol Urodyn; 2005; 24(3):215-25. PubMed ID: 15747340
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the Urinary Symptom Profile (USP) questionnaire.
Haab F; Richard F; Amarenco G; Coloby P; Arnould B; Benmedjahed K; Guillemin I; Grise P
Urology; 2008 Apr; 71(4):646-56. PubMed ID: 18313122
[TBL] [Abstract][Full Text] [Related]
5. The urgency perception score: validation and test-retest.
Blaivas JG; Panagopoulos G; Weiss JP; Somaroo C; Chaikin DC
J Urol; 2007 Jan; 177(1):199-202. PubMed ID: 17162042
[TBL] [Abstract][Full Text] [Related]
6. Urgency is the core symptom of female overactive bladder syndrome, as demonstrated by a statistical analysis.
Hung MJ; Ho ES; Shen PS; Sun MJ; Lin AT; Chen GD;
J Urol; 2006 Aug; 176(2):636-40. PubMed ID: 16813910
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a new treatment outcome score for men with LUTS.
Weiss JP; Blaivas JG; Tash Anger JA; Di Blasio CJ; Panagopoulos G; Gerboc J
Neurourol Urodyn; 2004; 23(2):88-93. PubMed ID: 14983416
[TBL] [Abstract][Full Text] [Related]
8. Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB-SAT-q).
Margolis MK; Fox KM; Cerulli A; Ariely R; Kahler KH; Coyne KS
Neurourol Urodyn; 2009; 28(5):416-22. PubMed ID: 19030182
[TBL] [Abstract][Full Text] [Related]
9. A prospective assessment of overactive bladder symptoms in a cohort of elderly women who underwent transvaginal surgery for advanced pelvic organ prolapse.
Foster RT; Barber MD; Parasio MF; Walters MD; Weidner AC; Amundsen CL
Am J Obstet Gynecol; 2007 Jul; 197(1):82.e1-4. PubMed ID: 17618768
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiological aspects of nocturia in a danish population of men and women age 60 to 80 years.
Bing MH; Moller LA; Jennum P; Mortensen S; Lose G
J Urol; 2007 Aug; 178(2):552-7. PubMed ID: 17570415
[TBL] [Abstract][Full Text] [Related]
11. Is the prevalence of overactive bladder overestimated? A population-based study in Finland.
Tikkinen KA; Tammela TL; Rissanen AM; Valpas A; Huhtala H; Auvinen A
PLoS One; 2007 Feb; 2(2):e195. PubMed ID: 17332843
[TBL] [Abstract][Full Text] [Related]
12. The psychometric validation of the OAB family impact measure (OAB-FIM).
Coyne KS; Matza LS; Brewster-Jordan J; Thompson C; Bavendam T
Neurourol Urodyn; 2010 Mar; 29(3):359-69. PubMed ID: 19274760
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire.
Piault E; Evans CJ; Espindle D; Kopp Z; Brubaker L; Abrams P
Neurourol Urodyn; 2008; 27(3):179-90. PubMed ID: 17565727
[TBL] [Abstract][Full Text] [Related]
14. Reliability and validity of the overactive bladder symptom score in Hong Kong Chinese.
Yiu MK; Li CM; Hou SM; Wong CW; Tam S; Chu SK
Hong Kong Med J; 2013 Dec; 19(6):504-10. PubMed ID: 23787257
[TBL] [Abstract][Full Text] [Related]
15. Understanding the elements of overactive bladder: questions raised by the EPIC study.
Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
[TBL] [Abstract][Full Text] [Related]
16. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
[TBL] [Abstract][Full Text] [Related]
17. Validating the incontinence symptom severity index: a self-assessment instrument for voiding symptom severity in women.
Twiss C; Triaca V; Anger J; Patel M; Smith A; Kim JH; Raz S; RodrÃguez LV
J Urol; 2009 Nov; 182(5):2384-91. PubMed ID: 19758631
[TBL] [Abstract][Full Text] [Related]
18. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
[TBL] [Abstract][Full Text] [Related]
19. Psychometric analysis of international prostate symptom score for female lower urinary tract symptoms.
Okamura K; Nojiri Y; Osuga Y; Tange C
Urology; 2009 Jun; 73(6):1199-202. PubMed ID: 19371926
[TBL] [Abstract][Full Text] [Related]
20. Symptom severity and patient perceptions in overactive bladder: how are they related?
Homma Y; Gotoh M
BJU Int; 2009 Oct; 104(7):968-72. PubMed ID: 19338560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
